Related Experiment Video
Updated: Aug 10, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Increasing threat of Gram-positive bacterial infections in the intensive care unit setting
1Department of Epidemiology, Rollins School of Public Health of Emory University, Atlanta, GA, USA.
Abstract:
The effects of resistance are being noted on an increasing scale in the intensive care unit (ICU). Around the world, new epidemiologic patterns of ICU occurrence are being observed for Gram-positive multidrug-resistant organisms. Current problems include the appearance of insusceptibility to vancomycin and other glycopeptides in Staphylococcus aureus organisms that are virulent enough to cause infection in patients with normal host defenses. In addition, multidrug-resistant organisms like methicillin-resistant S.aureus are spreading from healthcare to community settings, and community organisms like Streptococcus pneumoniae are spreading to healthcare settings. Focal persistence and subsequent worldwide spread of enterococci resistant to vancomycin and other glycopeptides and multiple-resistance mechanisms in the same organism also require attention. Strategies such as multidisciplinary management of infections, appropriate infection control measures, and surveillance of resistance patterns are necessary to address the problem of resistance. Intensivists have been prominent in research and control efforts in this field and should continue to lead future efforts.
Insights
Multidrug-resistant organisms are a growing concern in intensive care units (ICUs), with vancomycin-resistant Staphylococcus aureus and spreading resistant bacteria posing significant threats. Effective strategies and intensivist leadership are crucial for combating this global challenge.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Increasing prevalence of multidrug-resistant organisms (MDROs) in intensive care units (ICUs) globally.
- Emergence of vancomycin-resistant Staphylococcus aureus and other resistant Gram-positive bacteria.
- Cross-contamination of resistant organisms between healthcare and community settings.
Purpose of the Study:
- To highlight the growing problem of antimicrobial resistance in ICUs.
- To discuss the evolving epidemiologic patterns of MDROs.
- To emphasize the need for strategic interventions and leadership in resistance control.
Main Methods:
- Observational analysis of current trends in antimicrobial resistance.
- Review of emerging resistance mechanisms and organism spread.
- Synthesis of current and proposed control strategies.
Main Results:
- Significant increase in MDROs, including vancomycin-resistant Staphylococcus aureus.
- Observed spread of resistant organisms between healthcare and community environments.
- Identification of enterococci with resistance to vancomycin and multiple mechanisms.
Conclusions:
- Multidrug resistance in ICUs is a critical and expanding global issue.
- Integrated strategies including infection control, surveillance, and multidisciplinary management are essential.
- Intensivists must continue to lead research and control efforts against antimicrobial resistance.
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pyelonephritis II: Diagnostic Studies and Management
Clinical Significance of Antibiotic Resistance
Pneumonia I: Introduction

